CanDapi

Dry Powder Inhaler

Health Tech & Life Sciences
Non Active, Sep 2025 ceased to operate
Seed Yeruham Founded 2022
LinkedIn
Total raised
$3.5M
Last: Seed 2022-07
Stage
Seed
Founded
2022
Headcount
2
HQ
Yeruham
Sector
Health Tech & Life Sciences

About

CanDapi is a breakthrough in delivering medications and cannabinoids to the lungs by dry powder inhalator. It is suitable for any generic and systemic medical powder drugs. It is easy to use for all patients.

Funding history · 1 round · $3.5M total

2022-07
Seed $3.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2C

Tags

drug-deliveryrespiratorymedical-cannabiscannabismedical-devices